Angiotensin II receptor antagonists: Role in hypertension, cardiovascular disease, and renoprotection

被引：15
作者：
Appel, GB [1 ]
Appel, AS [1 ]
机构：
[1] Columbia Univ Coll Phys & Surg, Dept Med, Div Nephrol, New York, NY 10032 USA
来源：
PROGRESS IN CARDIOVASCULAR DISEASES | 2004年 / 47卷 / 02期
关键词：
D O I：
10.1016/j.pcad.2004.04.005
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：105 / 115
页数：11
相关论文
共 58 条
[21]   Angiotensin receptors and their therapeutic implications [J].
Griendling, KK ;
Lassegue, B ;
Alexander, RW .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1996, 36 :281-306
[22]   HEMODYNAMIC AND HUMORAL EFFECTS OF THE ANGIOTENSIN-II ANTAGONIST LOSARTAN IN ESSENTIAL-HYPERTENSION [J].
GROSSMAN, E ;
PELEG, E ;
CARROLL, J ;
SHAMISS, A ;
ROSENTHAL, T .
AMERICAN JOURNAL OF HYPERTENSION, 1994, 7 (12) :1041-1044
[23]   Angiotensin IV AT4-receptor system in the rat kidney [J].
Handa, RK ;
Krebs, LT ;
Harding, JW ;
Handa, SE .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 1998, 274 (02) :F290-F299
[24]   A comparison of the angiotensin II antagonists valsartan and losartan in the treatment of essential hypertension [J].
Hedner, T ;
Oparil, S ;
Rasmussen, K ;
Rapelli, A ;
Gatlin, M ;
Kobi, P ;
Sullivan, J ;
Oddou-Stock, P .
AMERICAN JOURNAL OF HYPERTENSION, 1999, 12 (04) :414-417
[25]   Recent progress in angiotensin II type 2 receptor research in the cardiovascular system [J].
Horiuchi, M ;
Akishita, M ;
Dzau, VJ .
HYPERTENSION, 1999, 33 (02) :613-621
[26]  
Inagami T, 1999, J AM SOC NEPHROL, V10, pS57
[27]   Maximal suppression of renin-angiotensin system in nonproliferative glomerulonephritis [J].
Iodice, C ;
Balletta, MM ;
Minutolo, R ;
Giannattasio, P ;
Tuccillo, S ;
Bellizzi, V ;
D'Amora, M ;
Rinaldi, G ;
Signoriello, G ;
Conte, G ;
De Nicola, L .
KIDNEY INTERNATIONAL, 2003, 63 (06) :2214-2221
[28]   Single versus dual blockade of the resin-angiotensin system (angiotensin-converting enzyme inhibitors and/or angiotensin II receptor blockers) in diabetic nephropathy [J].
Jacobsen, P ;
Rossing, K ;
Parving, HH .
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2004, 13 (03) :319-324
[29]   Comparative efficacy of two angiotensin II receptor antagonists, irbesartan and losartan, in mild-to-moderate hypertension [J].
Kassler-Taub, K ;
Littlejohn, T ;
Elliott, W ;
Ruddy, T ;
Adler, E .
AMERICAN JOURNAL OF HYPERTENSION, 1998, 11 (04) :445-453
[30]   Long-term comparison of losartan and enalapril on kidney function in hypertensive type 2 diabetics with early nephropathy [J].
Lacourcière, Y ;
Bélanger, A ;
Godin, C ;
Hallé, JP ;
Ross, S ;
Wright, N ;
Marion, J .
KIDNEY INTERNATIONAL, 2000, 58 (02) :762-769
123456